POMC and ACTH-producing pituitary gland adenoma: Canertinib, which targets multiple ErbB receptors, suppressed POMC mRNA and ACTH secretion in cultured human corticotroph adenomas, with a 70% reduction seen in those with higher ErbB expression (72).